Table 2: Baseline and posttreatment endocrine and metabolic parameters of groups A and B of PCOS patients.

⁢Group A ()⁢Group B ()
BaselineMI plus DCIp valueBaselineplacebo value

FSH (mIU/mL)5.86 ± 1.754.96 ± 1.74ns5.67 ± 1.115.47 ± 0.63ns
LH (mIU/mL)12.5 ± 88.5 ± 4.0411.27 ± 7.211.25 ± 5.35ns
E (pg/mL)47.06 ± 18.20107.42 ± 92.8650.37 ± 19.4552 ± 20.2ns
Fasting insulin (μU/mL)20.19 ± 8.1410.74 ± 5.4618 ± 817.8 ± 8.2ns
Fasting glucose (mg/dL)85 ± 5.9686 ± 7.12ns86.2 ± 9.184.73 ± 8.3ns
Free testosterone (ng/dL)0.76 ± 0.200.62 ± 0.150.85 ± 0.220.83 ± 0.2ns
SHBG (nmol/L)24.11 ± 10.3535.85 ± 24.320.44 ± 8.7721.36 ± 7.57ns
Androstenedione (ng/mL)4.25 ± 1.484.01 ± 1.70ns3.48 ± 1.213.12 ± 2.23ns
DHEAS (μg/dL)327.32 ± 150.89347.6 ± 170.98ns337.95 ± 155.79315.83 ± 145.59ns
HOMA 3.38 ± 1.971.97 ± 1.483.48 ± 2.022.8 ± 1.4ns

E, 17-beta-Estradiol; P, progesterone; 17OHP, 17-OH-progesterone; SHBG, Sex Hormone Binding Globulin; DHEAS, dehydroepiandrosterone sulphate.